Song P, Rudan D, Zhu Y, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019;7(8):E1020–E30. https://doi.org/10.1016/S2214-109x(19)30255-4
Allison MA, Ho E, Denenberg JO, et al. Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prev Med. 2007;32(4):328–33. https://doi.org/10.1016/J.Amepre.2006.12.010
Criqui MH, Matsushita K, Aboyans V, et al. Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association. Circulation. 2021;144(9):E171–E91. https://doi.org/10.1161/Cir.0000000000001005
Article PubMed PubMed Central Google Scholar
Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health And Nutrition Examination Survey, 1999-2000. Circulation. 2004;110(6):738–43. https://doi.org/10.1161/01.Cir.0000137913.26087.F0
Meijer WT, Hoes AW, Rutgers D, et al. Peripheral arterial disease in the elderly: the Rotterdam study. Arterioscler Thromb Vasc Biol. 1998;18(2):185–92. https://doi.org/10.1161/01.Atv.18.2.185
Article CAS PubMed Google Scholar
Criqui MH, Vargas V, Denenberg JO, et al. Ethnicity and peripheral arterial disease: the San Diego Population Study. Circulation. 2005;112(17):2703–7. https://doi.org/10.1161/Circulationaha.105.546507
Eslami MH, Zayaruzny M, Fitzgerald GA. The adverse effects of race, insurance status, and low income on the rate of amputation in patients presenting with lower extremity ischemia. J Vasc Surg. 2007;45(1):55–9. https://doi.org/10.1016/J.Jvs.2006.09.044
Hirsch AT, Allison MA, Gomes AS, et al. A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association. Circulation. 2012;125(11):1449–72. https://doi.org/10.1161/Cir.0b013e31824c39ba
Srivaratharajah K, Abramson BL. Women and peripheral arterial disease: a review of sex differences in epidemiology, clinical manifestations, and outcomes. Can J Cardiol. 2018;34(4):356–61. https://doi.org/10.1016/J.Cjca.2018.01.009
Vart P, Coresh J, Kwak L, et al. Socioeconomic status and incidence of hospitalization with lower-extremity peripheral artery disease: atherosclerosis risk in communities study. J Am Heart Assoc. 2017;6(8) https://doi.org/10.1161/Jaha.116.004995
Pande RL, Creager MA. Socioeconomic inequality and peripheral artery disease prevalence in US adults. Circ Cardiovasc Qual Outcomes. 2014;7(4):532–9. https://doi.org/10.1161/Circoutcomes.113.000618
Article PubMed PubMed Central Google Scholar
Society For Vascular Surgery Lower Extremity Guidelines Writing G, Conte MS, Pomposelli FB, et al. Society For Vascular Surgery Practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg. 2015;61(3 Suppl):2s–41s. https://doi.org/10.1016/J.Jvs.2014.12.009
Alahdab F, Wang AT, Elraiyah TA, et al. A systematic review for the screening for peripheral arterial disease in asymptomatic patients. J Vasc Surg. 2015;61(3 Suppl):42s–53s. https://doi.org/10.1016/J.Jvs.2014.12.008
Golledge J. Update on the pathophysiology and medical treatment of peripheral artery disease. Nat Rev Cardiol. 2022;19(7):456–74. https://doi.org/10.1038/S41569-021-00663-9
Bonaca MP, Hamburg NM, Creager MA. Contemporary medical management of peripheral artery disease. Circ Res. 2021;128(12):1868–84. https://doi.org/10.1161/Circresaha.121.318258
Article CAS PubMed Google Scholar
Nastasi DR, Moxon JV, Norman R, et al. The cost-effectiveness of intensive low-density lipoprotein cholesterol lowering in people with peripheral artery disease. J Vasc Surg. 2021;73(4):1396–403. https://doi.org/10.1016/J.Jvs.2020.08.129
Mcdermott MM, Guralnik JM, Tian L, et al. Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking And Leg Circulation Study). J Am Coll Cardiol. 2009;53(12):1056–62. https://doi.org/10.1016/J.Jacc.2008.09.063
Article PubMed PubMed Central Google Scholar
Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43(10):1731–7. https://doi.org/10.1016/J.Jacc.2003.12.047
Article CAS PubMed Google Scholar
Csordas A, Bernhard D. The biology behind the atherothrombotic effects of cigarette smoke. Nat Rev Cardiol. 2013;10(4):219–30. https://doi.org/10.1038/Nrcardio.2013.8
Article CAS PubMed Google Scholar
Yarlioglues M, Ardic I, Dogdu O, et al. The acute effects of passive smoking on mean platelet volume in healthy volunteers. Angiology. 2012;63(5):353–7. https://doi.org/10.1177/0003319711420131
Goncalves RB, Coletta RD, Silverio KG, et al. Impact of smoking on inflammation: overview of molecular mechanisms. Inflamm Res. 2011;60(5):409–24. https://doi.org/10.1007/S00011-011-0308-7
Article CAS PubMed Google Scholar
Gordon T, Kannel WB. Predisposition to atherosclerosis in the head, heart, and legs. The Framingham Study. Jama. 1972;221(7):661–6.
Article CAS PubMed Google Scholar
Bainton D, Sweetnam P, Baker I, Elwood P. Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study. Br Heart J. 1994;72(2):128–32. https://doi.org/10.1136/Hrt.72.2.128
Article CAS PubMed PubMed Central Google Scholar
Lassila R, Lepantalo M. Cigarette smoking and the outcome after lower limb arterial surgery. Acta Chir Scand. 1988;154(11-12):635–40.
Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College Of Cardiology/American Heart Association Task Force On Clinical Practice Guidelines. Circulation. 2017;135(12):E686–725. https://doi.org/10.1161/Cir.0000000000000470
Spangler EL, Goodney PP. Smoking cessation strategies in vascular surgery. Semin Vasc Surg. 2015;28(2):80–5. https://doi.org/10.1053/J.Semvascsurg.2015.10.001
James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). Jama. 2014;311(5):507–20. https://doi.org/10.1001/Jama.2013.284427
Article CAS PubMed Google Scholar
Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APHA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College Of Cardiology/American Heart Association Task Force On Clinical Practice Guidelines. Circulation. 2018;138(17):E484–594. https://doi.org/10.1161/Cir.0000000000000596
Mehler PS, Coll JR, Estacio R, et al. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation. 2003;107(5):753–6. https://doi.org/10.1161/01.Cir.0000049640.46039.52
Zankl AR, Ivandic B, Andrassy M, et al. Telmisartan improves absolute walking distance and endothelial function in patients with peripheral artery disease. Clin Res Cardiol. 2010;99(12):787–94. https://doi.org/10.1007/S00392-010-0184-0
Article CAS PubMed Google Scholar
Ostergren J, Sleight P, Dagenais G, et al. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J. 2004;25(1):17–24. https://doi.org/10.1016/J.Ehj.2003.10.033
Article CAS PubMed Google Scholar
Group Sr, Wright JT Jr, Williamson JD, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–16. https://doi.org/10.1056/Nejmoa1511939
Ference BA, Ginsberg HN, Graham I, et al. Low-Density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459–72. https://doi.org/10.1093/Eurheartj/Ehx144
Article CAS PubMed PubMed Central Google Scholar
Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation. 2004;110(2):227–39. https://doi.org/10.1161/01.Cir.0000133317.49796.0e
Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APHA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College Of Cardiology/American Heart Association Task Force On Clinical Practice Guidelines. Circulation. 2019;139(25):E1082–E143. https://doi.org/10.1161/Cir.0000000000000625
Comments (0)